scispace - formally typeset
Open AccessJournal ArticleDOI

The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB

TLDR
The authors in this paper reviewed the data presented in the global TB report and discussed the current constraints in global response and emphasized that ending the TB epidemic will require bold leadership, optimization of existing interventions, widespread coverage, addressing social determinants of TB and importantly mobilization of adequate funding required for TB care and prevention.
About
This article is published in International Journal of Infectious Diseases.The article was published on 2022-03-01 and is currently open access. It has received 102 citations till now. The article focuses on the topics: Medicine & Tuberculosis.

read more

Citations
More filters
Journal ArticleDOI

World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic

TL;DR: The World Health Organization (WHO) and STOP TB Partnership theme for World TB Day 24th March, 2022 is “Invest to End TB. Save Lives” (WHO, 2022a). Global political and scientific attention continues to be focussed on the COVID-19 pandemic as discussed by the authors .
Journal ArticleDOI

Machine learning analysis of SERS fingerprinting for the rapid determination of Mycobacterium tuberculosis infection and drug resistance

TL;DR: In this article , a set of supervised machine learning algorithms were used to dissect surface enhanced Raman spectroscopy (SERS) spectra generated via a handheld SERS spectrometer, through which sputum samples with or without Mtb strains were successfully differentiated.
Journal ArticleDOI

Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review

TL;DR: Understanding the therapeutic properties of flavonoids can be useful for the future treatment of TB, and the small molecules-based treatments hold significant potential to overcome drug resistance and even provide opportunities for multimodal therapy.
Journal ArticleDOI

Immunosensors—The Future of Pathogen Real-Time Detection

TL;DR: In this article , the advances in the field of immunosensor usage in pathogenic microorganism- and toxin-detection, are described, and a very important potential use for them in various transport systems, where the risk of contamination by bioagents is very high.
Journal ArticleDOI

Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial

TL;DR: In this paper , the authors evaluated treatment satisfaction and usability of a digital medication event reminder and monitor (MERM) device for patients with tuberculosis to address the prespecified secondary endpoint of the SELFTB trial.
References
More filters

Global tuberculosis report (2014)

TL;DR: The 18th global report on tuberculosis (TB) provides a comprehensive and up-to-date assessment of the TB epidemic and of the progress made in TB prevention, care and control at global, regional and country level, using data reported by 197 countries and territories.
Journal ArticleDOI

Towards tuberculosis elimination: an action framework for low-incidence countries

Knut Lönnroth, +72 more
TL;DR: An action framework for countries with low tuberculosis (TB) incidence sets out priority interventions required for these countries to progress first towards “pre-elimination” and eventually the elimination of TB as a public health problem.
Journal ArticleDOI

The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus.

TL;DR: Tuberculosis is a contagious, infectious disease, due to Mycobacterium tuberculosis (MT) that has always been a permanent challenge over the course of human history, because of its severe social implications.
Journal ArticleDOI

World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update.

TL;DR: The 2020 revision of World Health Organization guidelines on the treatment of drug-resistant tuberculosis (TB) has highlighted the ongoing need for high-quality evidence and has reiterated the need for clinical trials and other research studies to contribute to the development of evidence-based policy.
Related Papers (5)
Trending Questions (2)
WHO global TB report 2022?

The provided paper is about the 2021 WHO global TB report. There is no information about the WHO global TB report for 2022 in the paper.

WHO Global TB Report 2022?

The provided paper is about the 2021 WHO Global TB Report. There is no information about the WHO Global TB Report 2022 in the paper.